Costamagna G, Bulajic M, Tringali A, Pandolfi M, Gabbrielli A, Spada C, Petruzziello L, Familiari P, Mutignani M
Digestive Endoscopy Unit, Catholic University of the Sacred Heart, A. Gemelli University Hospital, Largo A. Gemelli 8, 00168 Rome, Italy.
Endoscopy. 2006 Mar;38(3):254-9. doi: 10.1055/s-2005-921069.
Dominant pancreatic duct strictures located in the head of the pancreas in patients with severe chronic pancreatitis are often managed by endoscopic placement of a single plastic stent. Patients with refractory strictures after prolonged stenting require repeated stent replacement or surgical pancreaticojejunostomy. Placement of multiple plastic stents has proved effective in managing postoperative biliary strictures. The aim of this study was to investigate the feasibility, efficacy, and long-term results of multiple stenting of refractory pancreatic strictures in severe chronic pancreatitis.
19 patients with severe chronic pancreatitis (16 men, three women; mean age 45 years) and with a single pancreatic stent through a refractory dominant stricture in the pancreatic head underwent the following protocol: (i) removal of the single pancreatic stent; (ii) balloon dilation of the stricture; (iii) insertion of the maximum number of stents allowed by the stricture tightness and the pancreatic duct diameter; and (iv) removal of stents after 6 to 12 months.
The median number of stents placed through the major or minor papilla was 3, with diameters ranging from 8.5 to 11.5 Fr and length from 4 to 7 cm. Only one patient (5.5 %) had persistent stricture after multiple stenting. During a mean follow-up of 38 months after removal, 84 % of patients were asymptomatic, and 10.5 % had symptomatic stricture recurrence. No major complications were recorded.
Endoscopic multiple stenting of dominant pancreatic duct strictures in chronic pancreatitis is a feasible and safe technique. Multiple pancreatic stenting is promising in obtaining persistent stricture dilation on long-term follow-up in the setting of severe chronic pancreatitis.
重度慢性胰腺炎患者胰腺头部的主胰管狭窄通常采用内镜下放置单个塑料支架进行治疗。长期置入支架后出现难治性狭窄的患者需要反复更换支架或进行手术胰空肠吻合术。已证明放置多个塑料支架在治疗术后胆管狭窄方面有效。本研究的目的是探讨在重度慢性胰腺炎中对难治性胰腺狭窄进行多支架置入的可行性、有效性及长期结果。
19例重度慢性胰腺炎患者(16例男性,3例女性;平均年龄45岁),其胰腺头部难治性主胰管狭窄处已置入单个胰腺支架,接受了以下方案:(i)取出单个胰腺支架;(ii)对狭窄处进行球囊扩张;(iii)根据狭窄紧密度和胰管直径置入最大数量的支架;(iv)6至12个月后取出支架。
通过主乳头或副乳头置入的支架中位数为3个,直径范围为8.5至11.5 Fr,长度为4至7 cm。多支架置入后仅1例患者(5.5%)仍有持续性狭窄。在取出支架后的平均38个月随访期间,84%的患者无症状,10.5%有症状性狭窄复发。未记录到重大并发症。
内镜下对慢性胰腺炎主胰管狭窄进行多支架置入是一种可行且安全的技术。在重度慢性胰腺炎的情况下,多胰腺支架置入在长期随访中有望实现持续性狭窄扩张。